Literature DB >> 7949220

Vasoactive intestinal polypeptide increases whole pancreatic blood flow but does not affect islet blood flow in the rat.

L Jansson1.   

Abstract

To evaluate the effects of vasoactive intestinal peptide (VIP) on whole pancreatic blood flow and islet blood flow in the rat, anaesthetized adult rats were injected intravenously for 90 s with VIP (500 ng/kg body weight). Immediately after the injection, the whole pancreatic and islet blood flows were measured with a microsphere technique. VIP markedly increased the former but did not affect the latter. Thus, the fraction of the whole pancreatic blood flow diverted through the islets was decreased. In separate experiments, the effects of VIP on the blood glucose and serum insulin concentrations of anaesthetized animals were investigated. VIP caused an acute increase (after 2 min) in the latter, but did not affect the former. It is concluded that VIP exerts its blood flow stimulatory properties only on the exocrine pancreas, and that it may increase the serum insulin concentrations without an associated change in islet blood perfusion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7949220     DOI: 10.1007/bf00570545

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  27 in total

1.  Potent peripheral and splanchnic vasodilator peptide from normal gut.

Authors:  S I Said; V Mutt
Journal:  Nature       Date:  1970-02-28       Impact factor: 49.962

2.  Polypeptide with broad biological activity: isolation from small intestine.

Authors:  S I Said; V Mutt
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

3.  Effects of helodermin and VIP on insulin and glucagon secretion in the mouse.

Authors:  B Ahrén; B Falck
Journal:  Regul Pept       Date:  1991-01-01

4.  Glucose-induced changes in pancreatic islet blood flow mediated by central nervous system.

Authors:  L Jansson; C Hellerström
Journal:  Am J Physiol       Date:  1986-12

5.  Regional vascular influences of vasoactive intestinal polypeptide.

Authors:  W Blitz; G A Charbon
Journal:  Scand J Gastroenterol       Date:  1983-09       Impact factor: 2.423

6.  Comparison of helodermin, VIP and PHI in pancreatic secretion and blood flow in dogs.

Authors:  S J Konturek; N Yanaihara; W Pawlik; J Jaworek; K Szewczyk
Journal:  Regul Pept       Date:  1989-02

7.  VIP nerve fibres around peripheral blood vessels.

Authors:  R Uddman; J Alumets; L Edvinsson; R Håkanson; F Sundler
Journal:  Acta Physiol Scand       Date:  1981-05

8.  Innervation of the pancreas by substance P, enkephalin, vasoactive intestinal polypeptide and gastrin/CCK immunoractive nerves.

Authors:  L I Larsson
Journal:  J Histochem Cytochem       Date:  1979-09       Impact factor: 2.479

9.  Stimulation by glucose of the blood flow to the pancreatic islets of the rat.

Authors:  L Jansson; C Hellerström
Journal:  Diabetologia       Date:  1983-07       Impact factor: 10.122

10.  Terbutaline decreases the blood flow of the pancreatic islets but does not reduce the diabetogenic action of streptozotocin in the rat.

Authors:  L Jansson; D L Eizirik; S Sandler
Journal:  Eur J Pharmacol       Date:  1989-02-14       Impact factor: 4.432

View more
  3 in total

1.  Secretin and pancreatic islet blood flow in anesthetized rats: increased insulin secretion with no augmentation of blood perfusion.

Authors:  P O Carlsson; L Jansson
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

2.  Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat.

Authors:  G Bertrand; R Puech; Y Maisonnasse; J Bockaert; M M Loubatières-Mariani
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

3.  Characterisation of CART-containing neurons and cells in the porcine pancreas, gastro-intestinal tract, adrenal and thyroid glands.

Authors:  Nils Wierup; Anna Gunnarsdóttir; Eva Ekblad; Frank Sundler
Journal:  BMC Neurosci       Date:  2007-07-11       Impact factor: 3.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.